BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 27602403)

  • 21. Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells.
    Kato H; Ochiai-Shino H; Onodera S; Saito A; Shibahara T; Azuma T
    Open Biol; 2015 Feb; 5(2):140201. PubMed ID: 25652541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology.
    Shao Y; Sang J; Fu J
    Biomaterials; 2015 Jun; 52():26-43. PubMed ID: 25818411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H; Li T; Fan J; Li T; Fan L; Wang S; Weng X; Han Q; Zhao RC
    Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineered peptide modified hydrogel platform for propagation of human pluripotent stem cells.
    Richardson T; Wiegand C; Adisa F; Ravikumar K; Candiello J; Kumta P; Banerjee I
    Acta Biomater; 2020 Sep; 113():228-239. PubMed ID: 32603868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.
    Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P
    J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Pluripotent Stem Cell Differentiation into Functional Epicardial Progenitor Cells.
    Guadix JA; Orlova VV; Giacomelli E; Bellin M; Ribeiro MC; Mummery CL; Pérez-Pomares JM; Passier R
    Stem Cell Reports; 2017 Dec; 9(6):1754-1764. PubMed ID: 29173898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical strategies for stem cell biology and regenerative medicine.
    Zhu S; Wei W; Ding S
    Annu Rev Biomed Eng; 2011 Aug; 13():73-90. PubMed ID: 21513460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of Human Induced Pluripotent Stem Cells to Chondrocytes.
    Guzzo RM; Drissi H
    Methods Mol Biol; 2015; 1340():79-95. PubMed ID: 26445832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing Cell Competition in Human Pluripotent Stem Cell (hPSC) Cultures.
    Price CJ; Barbaric I
    Curr Protoc; 2022 May; 2(5):e435. PubMed ID: 35621694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium.
    Wang P; Liu X; Zhao L; Weir MD; Sun J; Chen W; Man Y; Xu HH
    Acta Biomater; 2015 May; 18():236-48. PubMed ID: 25712391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient engineering of vascularized ectopic bone from human embryonic stem cell-derived mesenchymal stem cells.
    Domev H; Amit M; Laevsky I; Dar A; Itskovitz-Eldor J
    Tissue Eng Part A; 2012 Nov; 18(21-22):2290-302. PubMed ID: 22731654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.
    Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F
    J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haematopoietic developmental potential of human pluripotent stem cell lines.
    Tesařová L; Simara P; Stejskal S; Koutná I
    Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
    Meng G; Liu S; Rancourt DE
    Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mimicking bone microenvironment for directing adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
    Lu Z; Roohani-Esfahani SI; Zreiqat H
    Methods Mol Biol; 2014; 1202():161-71. PubMed ID: 24155231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Culturing human pluripotent stem cells for regenerative medicine.
    Ozawa H; Matsumoto T; Nakagawa M
    Expert Opin Biol Ther; 2023; 23(6):479-489. PubMed ID: 37345510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteogenically differentiated mesenchymal stem cells and ceramics for bone tissue engineering.
    Ohgushi H
    Expert Opin Biol Ther; 2014 Feb; 14(2):197-208. PubMed ID: 24308323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.
    van den Heuvel NH; van Veen TA; Lim B; Jonsson MK
    J Mol Cell Cardiol; 2014 Feb; 67():12-25. PubMed ID: 24370890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum.
    Cordonnier T; Langonné A; Sohier J; Layrolle P; Rosset P; Sensébé L; Deschaseaux F
    Tissue Eng Part C Methods; 2011 Mar; 17(3):249-59. PubMed ID: 20822481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor 2 promotes osteogenic cell differentiation in the parthenogenetic murine embryonic stem cells.
    Kang H; Sung J; Jung HM; Woo KM; Hong SD; Roh S
    Tissue Eng Part A; 2012 Feb; 18(3-4):331-41. PubMed ID: 21902466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.